April 17-18, 2019
Boston, USA





Are you struggling to translate your immunological targets into validated, clinic-ready candidates? Collaborate with your peers at the Neuroimmunology Drug Development Summit (NIDD), the first industry-focused networking forum to learn and share insight on how to successfully target chronic neuroinflammation as a universal therapeutic for various neurological diseases. Focused on drug development, this meeting will enable you to effectively target neuroimmunological mechanisms to treat neurological disorders. With an emphasis on neurodegeneration, NIDD will provide a discussion-led platform for you to discover the best strategies and most innovative technologies to aid your future neuroimmunological research. Join the 70+ world class experts from AbbVie, Sanofi, Denali, Alector and Eisai to successfully guide the development of clinically efficacious therapeutics. Download the full event guide for the complete agenda.

"Outstanding conference "

Richard Wyse, Director of Research & Development, The Cure Parkinson’s Trust

“High level, focused meeting, with overall very interesting presentations and discussion by decision makers in CNS research and development”

Johan Luthman, Vice President,Clinical Development, Eisai